Amy Rappaport is the Senior Director of Translational Immunology at Gritstone bio., leading preclinical vaccine development for both oncology and infectious disease indications, including the advancement and optimization of Gritstone’s self-amplifying mRNA vaccines. She received her PhD in Cancer Biology from Cold Spring Harbor Laboratory and studied mouse models of cancer as a Post Doc at Genentech.